SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049148
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:11
Documents
6
Period of Report
2024-06-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A antx-def14a-2023.htm DEF 14A 823420
2 GRAPHIC img188362103_0.jpg GRAPHIC 15040
3 GRAPHIC img188362103_1.jpg GRAPHIC 4297
4 GRAPHIC img188362103_2.jpg GRAPHIC 4297
5 GRAPHIC img188362103_3.jpg GRAPHIC 1734313
6 GRAPHIC img188362103_4.jpg GRAPHIC 806461
  Complete submission text file 0000950170-24-049148.txt   4091893
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41331 | Film No.: 24883944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)